Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

Arcis Biotechnology and Teleflex in nucleic acid sampling licence agreement

Arcis Biotechnology logo 25.10.18Teleflex logo 25.10.18Nucleic acid sample preparation solution provider Arcis Biotechnology has signed a technology access agreement with New York Stock Exchange listed Teleflex Incorporated enabling Teleflex to use Arcis’ advanced nucleic acid sample preparation chemistry in the development of a novel clinical technology.

Arcis’ product portfolio offers the possibility of earlier, more accurate diagnostics testing from a variety of sample types using its rapid, two-step nucleic acid extraction and preservation technology. The company has an extensive patent portfolio covering DNA and RNA extraction and preservation for downstream processing by qPCR, RT-qPCR and rapid sequencing. The speed, simplicity and low-resource requirements of the platform provide a suitable solution for point-of-care, microfluidics or field-based testing in support of the two companies’ efforts to improve diagnostic testing and benefit patients and health care professionals.

For further information about Arcis Biotechnology visit www.arcisbio.com and for further information about Teleflex Incorporated visit www.tleflex.com

Last modified onSaturday, 27 October 2018 03:27